This week,  the European Foundation for Clinical Nanomedicine (CLINAM) in Basel gathered some of the brightest minds in the field for a plethora of insightful talks, presentations, and networking opportunities.
 
NVTx Co-Founder Pieter Cullis delivered a virtual presentation on “Rational Design of Lipid Nanoparticles for In Vivo Delivery of mRNA.”

NVTx CEO Dominik Witzigmann, PhD, spoke on “Advancing Lipid Nanoparticles for Safe and Efficient Nucleic Acid Delivery to Extrahepatic Tissues.”

NVTx’s VP Chemistry, Marco Ciufolini was an active participant.

NVTx thanks  Beat Loeffler and the Scientific Committee of CLINAM 2023 for organizing the event.